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E-mail address: hana@res.agr.hokudai.ac.jp (H. ShiThe RNA silencing suppressor 2b protein of Cucumber mosaic virus (CMV) is difﬁcult to produce in
Escherichia coli. We compared two CMV 2b proteins that differ in their toxicity against E. coli and
found that the acidic amino acid residues in the C-terminal signiﬁcantly affected the toxicity and
expression level of the protein in E. coli. In addition, in a DNA-binding assay, 2b had the ability to
bind to DNA, and this ability was affected by the charge on the C-terminal residues of 2b. We con-
cluded that the C-terminal residues were important for 2b’s DNA-binding ability, which may partly
explain the toxicity of the protein.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cucumber mosaic virus (CMV) is the major species in the genus
Cucumovirus, which has tripartite plus-sense RNAs designated
RNAs 1, 2 and 3 in decreasing order of molecular weight. On the
basis of the RNA sequences, CMV is further classiﬁed into three
subgroups, IA, IB and II [1]. Tomato aspermy virus (TAV), which is
also a cucumovirus, is more similar to subgroup II strains of CMV
than to subgroup I strains [2]. Cucumoviruses have a subgenomic
RNA, RNA4A that is generated from the 30 end of RNA2 and encodes
the 2b protein (2b) [3]. Cucumovirus 2b protein has been shown to
play various roles in symptom induction and viral cell-to-cell and
systemic movements [4–8]. In addition, 2b acts as a suppressor
of RNA silencing [9], a host defense mechanism against viral infec-
tion. The 2b protein interferes with RNA silencing by directly
blocking the slicer activity of Argonaute1 (AGO1), a crucial compo-
nent of the RNA-induced silencing complex (RISC) [10]. Further-
more, cucumovirus 2b can bind to small RNAs [11,12], suggesting
that 2b inhibits RNA silencing by binding to double-stranded
RNA (dsRNA) and short-interfering RNA (siRNA), which trigger
the RNA silencing pathway. Thus, 2b seems to have multiple ways
of suppressing RNA silencing in plant cells; further investigationschemical Societies. Published by E
Nishi9, Sappporo 060-8589,
mura).are still needed to understand how 2b coordinately controls
plant–virus interactions.
To elucidate the molecular details of the functions of 2b in
plant–virus interactions using conventional approaches (e.g., crys-
tal structure analyses, in vitro binding assay, etc.), we need to
establish an efﬁcient expression system using Escherichia coli.
However, 2b tends to become insoluble in plant and E. coli cells
[11,13] and often inhibits growth of E. coli cells probably from a
toxic effect [14]. For example, attempts to express 2b of CMV sub-
group I in E. coli were not successful [14], while the 2b proteins of
Q-CMV (subgroup II strain) and TAV were somehow expressed in
E. coli although the expression systems are still not efﬁcient
[3,14]. In our previous work, efﬁcient expression of the 2b protein
of CMV-Y (subgroup I strain) in E. coliwas so difﬁcult that we man-
aged to express 2b together with a FLAG tag using the wheat germ
in vitro translation system [11]. On the other hand, we found that
2b of HL-CMV (also subgroup I strain) could be efﬁciently ex-
pressed in E. coli as fusion protein with maltose binding protein
(MBP) without any problems [15].
In this study, we examined the 2b proteins of HL-CMV and
CMV-Y (HL2b and Y2b, respectively) for differences in their expres-
sion in E. coli and found that the 104th acidic amino acid in Y2b
contributed to the toxicity against E. coli cells, resulting in a low le-
vel of 2b expression. In addition, we found that CMV 2b could bind
to DNA in the N-terminal half region, and the charge on the C-ter-
minal residues was important to the DNA-binding ability of 2b. We
discuss a possible link between the toxicity of 2b and its ability to
bind DNA.lsevier B.V. All rights reserved.
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Fig. 1. Difference in expression of 2b proteins of HL-CMV and CMV-Y in E. coli. (A)
Expression of two CMV 2b proteins (HL2b and Y2b) as a fusion protein with MBP in
E. coli. The MBP-2bs were detected by CBB staining (upper panel) and Western blots
using anti-Y2b antibodies (lower panel). S and P represent the proteins in the
supernatant and the pellet fractions after centrifugation of E. coli cell lysate,
respectively. NI, no induction with IPTG. The arrowheads on the right of the blot
indicate MBP-2b proteins. The arrowhead on the left indicates a non-speciﬁc band
just above MBP-2b. (B) Alignment of the amino acid sequences of HL2b and Y2b.
Conserved residues are boxed.
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2.1. Plasmid construction
The 2b gene of HL-CMV [16] and of CMV-Y [17] was inserted be-
tween the EcoRI and either the SalI or BamHI sites in the pMAL-c2X
vector (New England BioLabs) to create pMAL:HL2b and pMA-
L:Y2b, respectively. The chimeric 2b gene between Y2b and HL2b
(pMAL:Y/HL) was ﬁrst generated by recombinant PCR using primer
pairs 50-GCGAATTCATGGAATTGAACGTAGGTG-30 and 50-CACGTT
CATATGGCGGCATGACC-30 for the 50 half of Y2b and 50-GGT
CATGCCGCCATATGAACGTG-30 and 50-GCGGATCCTCAGAAAGCA
CCTTCCGCCCATTTGTT-30 for the 30 half of HL2b. A single amino
acid mutation was then introduced into pMAL:Y/HL by PCR with
mutagenic primers to generate pMAL:Y/HL(77), pMAL:Y/HL(94)
and pMAL:Y/HL(104). Y2b mutants that have a single amino acid
substitution at position 104 were created by PCR using pMAL:Y2b
as a template with mutagenic primers to generate pMAL:Y(E104K),
pMAL:Y(E104R), pMAL:Y(E104H), pMAL:Y(E104A) and pMA-
L:Y(E104D); the 104th amino acid of Y2b (E, glutamic acid) was re-
placed with K (lysine), R (arginine), H (histidine), A (alanine) and D
(aspartic acid), respectively. Deletion mutants in the N-terminal
(1–70 residues) and C-terminal (64–110 residues) domains of
Y2b and HL2b were ampliﬁed by PCR and cloned in the pMAL-
c2X vector to generate pMAL:YDC(1–70), pMAL:YDN(64–110),
pMAL:HLDC(1–70) and pMAL:HLDC(64–110).
2.2. Analysis of the E. coli-expressed 2b protein
E. coli BL21 cells were transformed with one of the plasmids,
and 2b was expressed in E. coli as a C-terminal fusion protein with
MBP (MBP-2b). The E. coli cells were grown in 10 ml of RGM med-
ium (1% Bacto tryptone, 0.5% Bacto yeast extract, 0.5% NaCl, 0.2%
glucose, 100 lg/ml ampicillin) at 37 C. At OD595 = 0.5–0.6, the cul-
tures were induced with 0.3 mM isopropyl-b-D-thiogalactoside
(IPTG) and grown further at 37 C for 2 h. The cells were then har-
vested and resuspended in 1.5 ml of DNA-afﬁnity precipitation
(DNAP) buffer (20 mM HEPES-KOH [pH 7.9], 80 mM KCI, 1 mM
MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 10% (w/v) glycerol, 0.1% triton
X-100, 0.1 mM PMSF) followed by sonication (3  15 s) using a
Branson Soniﬁer 250. The lysate was clariﬁed at 15 000g for
15 min at 4 C, and MBP-2bs in the supernatant and pellet fractions
were analyzed by 10% SDS–PAGE with Coomassie brilliant blue
(CBB) staining. In Western blot analyses, MBP-2b was probed with
rabbit polyclonal antibodies raised against Y2b or MBP. To evaluate
the toxicity of 2b against E. coli cells, the OD595 of E. coli cultures
was measured at 30-min intervals for 6 h with or without IPTG
induction. To evaluate the growth inhibition more easily, we mea-
sured the OD595 of E. coli cultures 2 h after IPTG induction and cal-
culated relative cell growth by dividing the OD595 of IPTG-induced
cells by that of the non-induced cells.
2.3. DNA-afﬁnity precipitation (DNAP) assay
Random double-stranded DNA (dsDNA) library was obtained as
previously described [18]. To create biotinylated dsDNA, PCR was
performed using the 50 biotin-labeled reverse primer. A single-
stranded DNA (ssDNA) library was obtained by boiling the biotin-
ylated dsDNAs for 2 min followed by rapid cooling. MBP-2b in the
supernatant fraction was mixed with the biotinylated DNAs (1–
2.5 lg) and poly dI-dC (12 lg) (Roche) in DNAP buffer (ﬁnal vol-
ume 500 ll) and incubated for 1 h at 4 C with rotation. Dynabeads
M-280 Streptavidin (40 ll) (Invitrogen), which was prewashed
three times with DNAP buffer, was added to the mixture and incu-
bated further for 1 h at 4 C with rotation. The dynabeads–DNA–2b
complex was collected using a magnet, then washed ﬁve timeswith DNAP buffer to remove unbound 2bs and DNAs. Sample buf-
fer of SDS–PAGE was added to the beads after the ﬁfth wash, then
the mixture was boiled for 5 min. Each fraction was separated in
10% SDS–PAGE followed by Western blots with anti-MBP
antibodies.
2.4. Systematic evolution of ligands by exponential enrichment
(SELEX) in a DNAP assay
Strep-tag II peptide, which binds to Dynabeads M-280 Strepta-
vidin reversibly, was added to the N-terminal end of Y2b and HL2b
by PCR using a forward primer containing the peptide sequence,
and the PCR products were cloned into the pMAL-c2X vector. Ran-
dom dsDNA library was synthesized by PCR as described except
using a reverse primer without the biotin modiﬁcation. The DNA
aptamers bound to 2b were analyzed by SELEX in a DNAP assay
as summarized in Supplementary Fig. S1. The PCR-ampliﬁed DNAs
were ﬁnally cloned into the pGEM-T Easy vector (Promega), and
11–19 clones were sequenced.
3. Results
When two CMV 2b proteins (HL2b and Y2b) were expressed in
E. coli, HL2b was efﬁciently expressed in E. coli. Y2b, however, was
somewhat toxic to the growth of E. coli and failed to be expressed
efﬁciently in both the soluble (supernatant) and insoluble (pellet)
fractions (Fig. 1A). Y2b was barely detectable in the gel stained
with CBB, although there was a faint Y2b band in Western blots.
A comparison of their amino acid sequences in the open reading
frame (ORF) revealed that these 2bs had a high sequence identity
(94%); seven amino acids were different between HL2b and Y2b
(Fig. 1B). To clarify which amino acid residue(s) accounts for the
difference in the expression level in E. coli between HL2b and
Y2b, we constructed several mutant 2b proteins (Fig. 2A). We ﬁrst
compared the toxicity of HL2b and Y2b to E. coli cells by plotting
the growth curves for E. coli by time-course analysis, and by calcu-
lating the relative cell growth of E. coli at one period (2 h after IPTG
induction). The comparative observations showed that Y2b had se-
vere toxicity to E. coli compared to HL2b (Fig. 2B and C). In addition,
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Fig. 2. Comparison of the toxicity and expression level of mutant 2b proteins. (A) Schematic structures of the 2b proteins with various amino acid mutations. Red and green
bars represent the amino acid residues of HL2b and Y2b, respectively. (B) Representative growth curves of the E. coli cells transformed with pMAL:HL2b and pMAL:Y2b. Open
and closed squares indicate the growth curve either with or without IPTG induction, respectively. (C) Toxicity of 2b against E. coli cells at 2 h after IPTG induction. Relative cell
growth was calculated by dividing the OD595 of the IPTG-induced cells by that of non-induced cells. The value for HL2b-expressing E. coli was set at 1.0. (D) Expression levels
of the mutant 2b in E. coli. The mutant 2bs were separated in 10% SDS–PAGE and detected byWestern blots using anti-Y2b antibodies. S, supernatant; P, pellet. MBP-2b fusion
proteins are indicated by arrowhead because there is a faint non-speciﬁc band just above the target protein.
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half of Y2b and the C-terminal half of HL2b, had no toxicity to
E. coli, and Y/H-expressing E. coli grew as efﬁciently as HL2b-
expressing E. coli (Fig. 2C), indicating that the C-terminal half of
Y2b is involved in the toxicity to E. coli cells. To ﬁnd which amino
acid is the most effective one among the four amino acids, we fur-
ther constructed three mutant 2b proteins: Y/HL(77), Y/HL(94) and
Y/HL(104). When relative cell growth of E. coli was examined, only
a growth of Y/HL(104)-expressing E. coliwas dramatically inhibited
(Fig. 2C). Then, we constructed Y(E104K) whose background is Y2b
except for the 104th amino acid and found that Y(E104K)-express-
ing E. coli indeed grew well. We compared the expression level of
these mutants in E. coli by Western blots. In the results, all 2b pro-
teins that were not toxic to E. coli cells were efﬁciently expressed in
E. coli, while Y2b and Y/HL(104) that were toxic were not expressed
well in E. coli (Fig. 2D). These results indicate that the 104th amino
acid is involved in the 2b’s toxicity, leading to a decrease in total
protein and thus a low level of 2b expression in E. coli. We con-
ﬁrmed that introduced mutations on 2b did not affect the viral
symptom severity and accumulation in tobacco plants (Supple-
mentary Fig. S2). In addition, the protoplast assay showed that
there was little difference in the RNA silencing suppressor (RSS)
activity among the mutant 2b proteins (Supplementary Fig. S2).
We also assessed the solubility of HL2b, Y2b and the mutant
proteins. HL2b was detected more abundantly in the soluble frac-
tion than in the insoluble fraction but the expression levels of Y2b
were almost equal between the soluble and insoluble fractions in
Western blots (Fig. 1A). In comparative studies on the expression
in E. coli, HL2b had the highest solubility in the tested 2b proteins
(Supplementary Fig. S3), suggesting that the amino acids that
determine 2b solubility were at least not in the C-terminal residuesand that the toxicity of 2b does not seem to be linked to its
solubility.
The 104th amino acid of HL2b is a lysine (pI 9.74) and the cor-
responding amino acid of Y2b is a glutamic acid (pI 3.22) (Fig. 1B).
To investigate whether the charge of the 104th amino acid contrib-
utes to the toxicity of 2b, we further constructed four 2b mutants
that have a single amino acid substitution at position 104. When
these mutants were expressed in E. coli, only Y(E104D) that has
an acidic amino acid at position 104 was severely toxic and not ex-
pressed efﬁciently, just like Y2b (Fig. 3A and B). These results indi-
cate that a negative charge on the 104th amino acid is responsible
for the toxicity to E. coli cells.
In our previous study, we found that Y2b functions as a tran-
scriptional activator in yeast, but HL2b had no such activity (Sup-
plementary Fig. S4). Therefore, we hypothesized that Y2b may be
able to bind DNA and activate abnormal transcription, leading to
toxicity via a transcriptional disorder in E. coli. To investigate
whether 2b can bind to DNA, we performed the DNAP assay. In this
assay, when 2b is incubated with biotinylated random DNAs and if
2b binds to the biotinylated DNA, the 2b protein can then be
trapped by the beads and isolated as a 2b–DNA complex in the
eluted fraction. We examined the binding ability of Y2b, HL2b
and two mutant proteins Y(E104K) and Y(E104D) to dsDNA and
found that Y2b and Y(E104D) were actually detected in the eluted
fraction, while HL2b and Y(E104K) were barely detected (Fig. 4).
Furthermore, when single-stranded DNA was used, we observed
the same results (Fig. 4). These results suggest that the 104th ami-
no acid is important for DNA-binding, and also seems to be in-
volved in the toxicity to E. coli. We then examined whether the
C-terminal residues of 2b are directly involved in the DNA-binding
ability and/or the toxicity to E. coli cells. Deletion mutants of N- or
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Fig. 3. Toxicity of 2b to E. coli cells is affected by the charge on amino acid 104. (A)
Toxicity of 2b proteins that contain a single amino acid mutation at position 104.
Relative cell growth was calculated as in Fig. 2C. (B) Expression levels of the mutant
2bs in E. coli. The MBP-2b fusion proteins were detected with anti-Y2b antibodies as
in Fig. 2D. I, induction with IPTG. NI, no induction with IPTG. MBP-2b fusion
proteins are indicated by arrowheads because there is a faint non-speciﬁc band just
above the target protein (see NI lanes).
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Fig. 4. DNA-binding ability of CMV 2b in the DNAP assay. The 2b proteins were
produced as a C-terminal fusion protein with MBP. In this assay, MBP did not bind
to DNA. Binding of 2b to Dynabeads mediated by biotinylated dsDNAs and ssDNAs
was detected by Western blots using anti-MBP antibodies. I, input; FT, ﬂow
through; W, ﬁfth wash fraction; E, eluted fraction.
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Fig. 5. The N-terminal region of 2b has DNA-binding ability. (A) Schematic
structures of the 2b deletion mutants. Those mutant proteins were all produced
as C-terminal fusion protein with MBP. Red and green bars represent the amino acid
residues of HL2b and Y2b, respectively. (B) Toxicity of the 2b deletion mutants.
Relative cell growth was calculated as in Fig. 2C. (C) DNA-binding ability of 2b
deletion mutants in the DNAP assay. Binding of mutant 2b proteins to Dynabeads
mediated by biotinylated dsDNAs was detected by Western blots using anti-MBP
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Table 1
The DNA aptamers selected by HL2b and Y2b in SELEX in the DNAP assay.
Selected DNA sequence Number of clones
HL2b Y2b
TATTGGCGCAAAGTTA 2 11
AACATCGTCGAACGCC 7 8
CGATCATCTTTGGGGG 2 0
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to E. coli cells (Fig. 5A and B). In addition, the DNAP assay using ran-
dom dsDNAs revealed that the N-terminal half of 2b could bind to
dsDNA, but the C-terminal half did not (Fig. 5C), indicating that the
N-terminal region of 2b has the DNA-binding ability and the charge
on the 104th amino acid in the C-terminal affects the degree of
DNA-binding and the toxicity to E. coli cells.
To examine whether the 2b proteins have some sequence pref-
erence for DNA-binding, we used SELEX in a DNAP assay to try to
isolate any DNA aptamers to 2b. In the initial rounds of selection,
the sequences of DNA that bound to 2b varied and did not con-
verge. However, after six to nine rounds of selection, we ﬁnally
identiﬁed two sequences for Y2b and three sequences for HL2b
(Table 1). Although the binding ability of HL2b was below the
detection limit of the Western blots in Fig. 4, we identiﬁed the con-
verged DNA aptamers to HL2b in further rounds of selection after
Y2b aptamers were identiﬁed, indicating that the DNA-binding
ability is higher for Y2b than for HL2b. The two aptamers of Y2b
were the same as two of the aptamers of HL2b, but HL2b also
had another. These results suggest that, rather than binding to
DNA in a random manner, 2b appears to have some sequence pref-
erence for binding in the SELEX conditions used here.4. Discussion
When viral proteins are analyzed biochemically to identify their
functions, they are often produced in an E. coli expression system.
Particularly in the study of viral RSS, it is essential to produce an
RSS in E. coli to identify its point of operation in the silencing
machinery; e.g., when searching for factors that may interact with
an RSS. If E. coli-produced RSSs are insoluble, they may not fold
properly and may not function as expected. Because of their solu-
bility, sedimentation characteristics and toxicity to E. coli, the
K. Sueda et al. / FEBS Letters 584 (2010) 945–950 949Cucumovirus 2b proteins, especially for 2bs of CMV subgroup I
strains, are difﬁcult to produce in E. coli [11,13,14]. In earlier re-
ports, 2b has been produced in E. coli by many different methods
using recombinant proteins and even partial proteins [10–12],
but there are also contradictory results on the functions of 2b, per-
haps because the different E. coli expression systems used different
tags. Therefore, we here tried to establish an efﬁcient expression
system to produce 2b in E. coli to analyze 2b functions as precisely
as possible.
Among the 2b proteins of CMV subgroup I, we fortunately found
that 2b of HL-CMV isolated from a Japanese lily (HL2b) was efﬁ-
ciently produced in E. coli as a fusion protein with MBP unlike 2b
of CMV-Y (Y2b). To answer why most 2bs are not expressed well
in E. coli, we conducted comparative studies between HL2b and
Y2b. We found that a low level of 2b expression in E. coli was
caused by prominent growth depression of E. coli, and the negative
charge of the acidic amino acids on the C-terminal were responsi-
ble for the toxic effect. As shown in Supplementary Fig. S5, except
for three CMVs isolated from lily (HL, AJ831395 and AJ831396) and
CMV-Na, all other CMVs in the database contained two acidic ami-
no acid residues (E) at positions 104 and 107 in the C-terminal. Lily
CMVs may have preferentially adapted to lily by not having an
acidic amino acid at the C-terminal domain.
As for the C-terminal domain of 2b, we found that Y2b functions
as a transcriptional activator in the yeast and that the C-terminal is
important for the activity (Supplementary Fig. S4). In earlier work,
Ham et al. (1999) [19] also obtained a similar result for 2b of CMV-
Kor. Interestingly, HL2b was not active as a transcriptional activa-
tor. In this paper, we showed that 2b actually could bind to DNA,
and toxic 2bs showed the DNA-binding ability. We consider that
the DNA-binding of 2b at least partly causes the toxicity of 2b to
E. coli; if 2b binds to DNA in E. coli, the binding may cause a tran-
scriptional disorder and the subsequent toxicity to the E. coli cells.
We therefore conducted SELEX experiments to screen for speciﬁc
DNA sequences that 2b may recognize but found that the 2b-
bound sequences seemed to be rather random, although after
many rounds of selection, it did have some sequence preference.
The mechanism responsible for 2b’s toxicity to E. coli cells remains
to be solved, and we should also consider other possibilities. For
example, 2b may speciﬁcally interfere with an important factor(s)
that is critical to E. coli.
Cucumovirus 2bs have been shown to bind dsRNAs [11,12] and
viral genomic RNA in vitro [20], but there is no report describing
the 2b–DNA interaction and its role. Our present results are the ﬁrst
direct evidence that 2b can bind to DNA (both ssDNA and dsDNA)
although it has been previously predicted [13]. We found that the
2b’s DNA-binding site was in the N-terminal region, and the charge
on amino acid 104 in the C-terminal affected the DNA-binding abil-
ity. The binding site for dsRNAs has been also found to be in the pos-
itively charged amino acids in the N-terminal [12,13]. These
observations raise an intriguing possibility that 2b’s binding site
for dsRNA seems to be the same domain that binds to DNA and that
the ability to bind to dsRNA may also be affected by the C-terminal
residues. However, the comparison of the RSS activities of 2bs in
the protoplasts assay revealed that the C-terminal amino acid mod-
iﬁcations did not affect so much the RSS activity of 2b as did 2b’s
DNA-binding (Supplementary Fig. S2), suggesting that DNA-binding
activity of 2b is not directly involved in silencing suppression of 2b.
Aside from the toxicity of 2b to E. coli, the fact that 2b can bind
to DNA brings new insight to its role in plant cells. In CMV-infected
cells, 2b accumulates predominantly in or on the host cell nucleus
[13,21], suggesting a possible role for 2b in the nucleus. Indeed, we
detected genome-wide association between 2b and nuclear DNA in
CMV-infected Arabidopsis by a chromatin immunoprecipitation
(ChIP) assay coupled with Arabidopsis whole gnome tiling micro-
array (Supplementary Fig. S6). The results suggest that 2b perhapsinteracts with nuclear DNA in the chromatin structure directly or
indirectly, serving as a potential transcription factor controlling
gene expression in plant cells. We are now investigating whether
2b binds preferentially to any particular plant DNA sequences,
which may be involved in CMV infectivity or host defense
response.
In this study, we established a good E. coli expression system to
produce Y2b by single amino acid substitution in the C-terminal
residues. Because of the difﬁculty in producing 2b from the CMV
subgroup I in E. coli, there has been no success with X-ray analysis
of the crystalline structure of CMV 2b, although the structure of
TAV 2b, which lacks 32 residues of the C-terminal, has already
been reported [22]. The structure of CMV 2b can be predicted from
that of TAV 2b by homology modeling, but the effects of the miss-
ing C-terminal residues on DNA- or RNA-binding will never be elu-
cidated by such an analysis. Because there is a possibility that the
C-terminal of 2b regulates the nucleic acid-binding ability of the N-
terminal, it will be necessary to produce an intact 2b in E. coli over-
coming 2b’s toxicity and solubility to understand more deeply the
role of 2b in cells.
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